Unlock regulatory insights with Watson. Learn More
Return to Docket

Reclassification of the Drug Ondansetron (Zofran®) From Pregnancy Risk Category B, to C, D, or X After Consideration of new Safety Information

Type: Non-Rule Making
Docket Item Code P
Center CDER

Primary Documents (5)